Moy AP - Search Results

1

Merkel cell carcinoma among non-Caucasian patients: A retrospective case-control study.

Moy AP, Zhou D, Chen J, White C, Riedel ER, Pulitzer MP. Moy AP, et al. J Am Acad Dermatol. 2024 Apr 24:S0190-9622(24)00643-1. doi: 10.1016/j.jaad.2024.04.028. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38663746 No abstract available.

2

Aggressive Cutaneous Lymphomas and Their Mimics.

Moy AP, Pulitzer MP. Moy AP, et al. Surg Pathol Clin. 2023 Jun;16(2):361-383. doi: 10.1016/j.path.2023.01.009. Epub 2023 Mar 10. Surg Pathol Clin. 2023. PMID: 37149363 Review.

3

TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: A retrospective analysis of 39 cases.

Nocco SE, Ewalt MD, Moy AP, Lewis NE, Zhu M, Lezcano C, Busam K, Pulitzer M. Nocco SE, et al. Among authors: moy ap. J Am Acad Dermatol. 2024 Apr;90(4):839-841. doi: 10.1016/j.jaad.2023.11.051. Epub 2023 Dec 6. J Am Acad Dermatol. 2024. PMID: 38061444 No abstract available.

4

Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia patients: a 28-year institutional experience.

Cowen EA, Barrios DM, Pulitzer MP, Moy AP, Dusza SW, De Wolf S, Geyer MB, Markova A. Cowen EA, et al. Among authors: moy ap. Acta Haematol. 2023 Nov 21. doi: 10.1159/000535399. Online ahead of print. Acta Haematol. 2023. PMID: 37989105

5

Pruritus Related to Trastuzumab and Pertuzumab in HER2+ Breast Cancer Patients.

Gu S, Dusza S, Quigley E, Haliasos H, Markova A, Marchetti M, Moy A, Dang C, Modi S, Lake D, Noor S, Lacouture M. Gu S, et al. Res Sq [Preprint]. 2023 Apr 28:rs.3.rs-2679676. doi: 10.21203/rs.3.rs-2679676/v1. Res Sq. 2023. PMID: 37163123 Free PMC article. Updated. Preprint.

6

Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients.

Gu S, Dusza S, Quigley E, Haliasos H, Markova A, Marchetti M, Moy AP, Dang C, Modi S, Lake D, Noor S, Lacouture ME. Gu S, et al. Among authors: moy ap. Breast Cancer Res Treat. 2024 Jan;203(2):271-280. doi: 10.1007/s10549-023-07143-3. Epub 2023 Oct 13. Breast Cancer Res Treat. 2024. PMID: 37833451 Free PMC article.

7

Management of immune-related cutaneous adverse events with dupilumab.

Kuo AM, Gu S, Stoll J, Moy AP, Dusza SW, Gordon A, Haliasos EC, Janjigian Y, Kraehenbuehl L, Quigley EA, Chapman P, Lacouture ME, Markova A. Kuo AM, et al. Among authors: moy ap. J Immunother Cancer. 2023 Jun;11(6):e007324. doi: 10.1136/jitc-2023-007324. J Immunother Cancer. 2023. PMID: 37270183 Free PMC article.

8

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.

Gu SL, Maier T, Moy AP, Dusza S, Faleck DM, Shah NJ, Lacouture ME. Gu SL, et al. Among authors: moy ap. Pharmaceuticals (Basel). 2023 Nov 2;16(11):1548. doi: 10.3390/ph16111548. Pharmaceuticals (Basel). 2023. PMID: 38004414 Free PMC article.

9

Case report: Later onset of NRAS-mutant metastatic melanoma in a patient with a partially-excised giant congenital melanocytic nevus.

Costa BA, Zibara V, Singh V, Hamid O, Gandhi S, Moy AP, Betof Warner AS. Costa BA, et al. Among authors: moy ap. Front Med (Lausanne). 2022 Dec 8;9:1086473. doi: 10.3389/fmed.2022.1086473. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36569151 Free PMC article.

10

Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.

Drebin HM, Hosein S, Kurtansky NR, Nadelmann E, Moy AP, Ariyan CE, Bello DM, Brady MS, Coit DG, Marchetti MA, Bartlett EK. Drebin HM, et al. Among authors: moy ap. J Am Coll Surg. 2024 Jan 1;238(1):23-31. doi: 10.1097/XCS.0000000000000886. Epub 2023 Oct 23. J Am Coll Surg. 2024. PMID: 37870230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page